Skip to main content

Advertisement

Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis

Fig. 1

Validation of the antibodies used in RPPA. Tissue extracts (40 µg) derived from human muscle (M) were fractionated on SDS-PAGE gels, blotted against the indicated antibodies and processed for western blotting. Only antibodies that recognize a single protein band of the expected molecular mass were used in the study. The migration of molecular mass markers is indicated to the left

Back to article page